Integration of substance use treatment and medical care: A special issue of JSAT

Journal of Substance Abuse Treatment

Volumn 43, Issue 4, 2012, Pages 377-381

  Walley, Alexander Y ^a   Tetrault, Jeanette M ^b   Friedmann, Peter D ^c,d,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NALOXONE; NALTREXONE;

ALCOHOLISM; CHRONIC DISEASE; CHRONIC PAIN; COMORBIDITY; CONFIDENTIALITY; CONTROLLED DRUG RELEASE; DRUG DEPENDENCE TREATMENT; EMERGENCY CARE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATED HEALTH CARE SYSTEM; MEDICAL CARE; MENTAL HEALTH CARE; NOTE; OPIATE ADDICTION; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING; SUBSTANCE ABUSE;

ALCOHOL-RELATED DISORDERS; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; PERIODICALS AS TOPIC; QUALITY OF HEALTH CARE; SUBSTANCE-RELATED DISORDERS;

EID: 84868151084     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.09.002     Document Type: Note

References (42)

1. Academic E.D. SBIRT Research Collaborative. The impact of screening, brief intervention, and referral for treatment on emergency department patients' alcohol use. Annals of Emergency Medicine 2007, 50:699-710.
2. Babor T.F., McRee B.G., Kassebaum P.A., Grimaldi P.L., Ahmed K., Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): Toward a public health approach to the management of substance abuse. Substance Abuse 2007, 28:7-30.
3. Barry D.T., Irwin K.S., Jones E.S., et al. Opioids, chronic pain, and addiction in primary care. The Journal of Pain 2010, 11:1442-1450.
4. Bernstein E., Bernstein J., Feldman J., et al. An evidence based alcohol Screening, Brief Intervention and Referral to Treatment (SBIRT) curriculum for emergency department (ED) providers improves skills and utilization. Substance Abuse 2007, 28:79-92.
5. Choo E.K., Ranney M.L., Wong Z., Mello M.J. Attitudes toward technology-based health information among adult emergency department patients with drug or alcohol misuse. Journal of Substance Abuse Treatment 2012, 43:397-401.
6. Committee on Crossing the Quality Chasm. (2006). Adaptation to Mental Health and Addictive Disorders. Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series. (Accessed 9/6/2012 at =11470#toc). Washington, DC: National Academies Press. http://wwwnapedu/catalogphp?record_id.
7. Delgado M.K., Acosta C.D., Ginde A.A., et al. National survey of preventive health services in US emergency departments. Annals of Emergency Medicine 2011, 57:104-108.e2.
8. D'Onofrio G., Nadel E.S., Degutis L.C., et al. Improving emergency medicine residents' approach to patients with alcohol problems: A controlled educational trial. Annals of Emergency Medicine 2002, 40:50-62.
9. D'Onofrio G., Pantalon M.V., Degutis L.C., et al. Brief intervention for hazardous and harmful drinkers in the emergency department. Annals of Emergency Medicine 2008, 51:742 .e2-750 .e2.
10. Estee S., Wickizer T., He L., Shah M.F., Mancuso D. Evaluation of the Washington state screening, brief intervention, and referral to treatment project: Cost outcomes for Medicaid patients screened in hospital emergency departments. Medical Care 2010, 48:18-24.
11. Feuerstadt P., Bunim A.L., Garcia H., et al. Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients. Hepatology 2010, 51:1137-1143.
12. Fiellin D.A., Pantalon M.V., Chawarski M.C., et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. The New England Journal of Medicine 2006, 355:365-374.
13. Fleming M.F., Barry K.L., Manwell L.B., Johnson K., London R. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA : The Journal of the American Medical Association 1997, 277:1039-1045.
14. Friedmann P.D., Lemon S.C., Stein M.D., D'Aunno T.A. Accessibility of addiction treatment: Results from a national survey of outpatient substance abuse treatment organizations. Health Services Research 2003, 38:887-903.
15. Gentilello L.M., Ebel B.E., Wickizer T.M., Salkever D.S., Rivara F.P. Alcohol interventions for trauma patients treated in emergency departments and hospitals: A cost benefit analysis. Annals of Surgery 2005, 241:541-550.
16. Havard A., Shakeshaft A., Sanson-Fisher R. Systematic review and meta-analyses of strategies targeting alcohol problems in emergency departments: Interventions reduce alcohol-related injuries. Addiction 2008, 103:368-376. [discussion 77-8].
17. Humphreys K., McLellan A.T. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction 2011, 106:2058-2066.
18. Islam M.M., Topp L., Conigrave K.M., White A., Reid S.E., Grummett S., Haber P.S., Day C.A. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. Journal of Substance Abuse Treatment 2012, 43:440-445.
19. Jacobson I.M., McHutchison J.G., Dusheiko G., et al. Telaprevir for previously untreated chronic hepatitis C virus infection. The New England Journal of Medicine 2011, 364:2405-2416.
20. Kim T.W., Saitz R., Cheng D.M., Winter M.R., Witas J., Samet J.H. Effect of quality chronic disease management for alcohol and drug dependence on addiction outcomes. Journal of Substance Abuse Treatment 2012, 43:389-396.
21. Lee J.D., Grossman E., DiRocco D., et al. Extended-release naltrexone for treatment of alcohol dependence in primary care. Journal of Substance Abuse Treatment 2010, 39:14-21.
22. Lee J.D., Grossman E., Huben L., Manseau M., McNeely J., Rotrosen J., Stevens D., Gourevitch M.N. Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15months. Journal of Substance Abuse Treatment 2012, 43:458-462.
23. Litwin A.H., Harris K.A., Nahvi S., et al. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. Journal of Substance Abuse Treatment 2009, 37:32-40.
24. McCorry F., Garnick D.W., Bartlett J., Cotter F., Chalk M. Developing performance measures for alcohol and other drug services in managed care plans. Washington Circle Group. The Joint Commission Journal on Quality Improvement 2000, 26:633-643.
25. McGovern M.P., Lambert-Harris C., McHugo G.J., Giard J., Mangrum L. Improving the dual diagnosis capability of addiction and mental health treatment services: Implementation factors associated with program level changes. J Dual Diagnosis 2010, 6:237-250.
26. McGovern M.P., Urada D., Lambert-Harris C., Sullivan S.T., Mazade N.A. Development and initial feasibility of an organizational measure of behavioral health integration in medical care settings. Journal of Substance Abuse Treatment 2012, 43:402-409.
27. McKay J.R. Continuing care research: What we have learned and where we are going. Journal of Substance Abuse Treatment 2009, 36:131-145.
28. Pade P.A., Cardon K.E., Hoffman R.M., Geppert C.M.A. Prescription opioid abuse, chronic pain, and primary care: A Co-Occurring Disorders Clinic in the chronic disease model. J Subst Abuse Treat 2012, 43:446-450.
29. Pantalon M.V., Martino S., Dziura J., Li F.-Y., Owens P.H., Fiellin D.A., O'Connor P.G., D'Onofrio G. Development of a scale to measure practitioner adherence to a brief intervention in the emergency department. Journal of Substance Abuse Treatment 2012, 43:382-388.
30. Poordad F., McCone J., Bacon B.R., et al. Boceprevir for untreated chronic HCV genotype 1 infection. The New England Journal of Medicine 2011, 364:1195-1206.
31. Rumi M.G., Aghemo A., Prati G.M., et al. Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C. Gastroenterology 2010, 138:108-115.
32. Ryan S.A., Martel S., Pantalon M., et al. Screening, Brief Intervention, and Referral to Treatment (SBIRT) for alcohol and other drug use among adolescents: Evaluation of a pediatric residency curriculum. Substance Abuse 2012, 33:251-260.
33. Samet J.H., Friedmann P., Saitz R. Benefits of linking primary medical care and substance abuse services: Patient, provider, and societal perspectives. Archives of Internal Medicine 2001, 161:85-91.
34. Schwarz R., Zelenev A., Bruce R.D., Altice F.L. Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. Journal of Substance Abuse Treatment 2012, 43:451-457.
35. Sorensen J.L., Haug N.A., Larios S., Gruber V.A., Tulsky J., Powelson E., Logan D.P., Shapiro B. Directly administered antiretroviral therapy: Pilot study of a structural intervention in methadone maintenance. Journal of Substance Abuse Treatment 2012, 43:418-423.
36. Stein M.R., Soloway I.J., Jefferson K.S., Roose R.J., Arnsten J.H., Litwin A.H. Concurrent group treatment for hepatitis C: Implementation and outcomes in a methadone maintenance treatment program. Journal of Substance Abuse Treatment 2012, 43:424-432.
37. Substance Abuse and Mental Health Services Administration. (2012). Screening, Brief Intervention and Referral to Treatment (SBIRT). (Accessed 8/8/2012, at http://www.samhsa.gov/prevention/sbirt/.);2012.
38. Sullivan L.E., Barry D., Moore B.A., et al. A trial of integrated buprenorphine/naloxone and HIV clinical care. Clinical Infectious Diseases 2006, 43(Suppl 4):S184-S190.
39. Tetrault J.M., Moore B.A., Barry D.T., O'Connor P.G., Schottenfeld R., Fiellin D.A., Fiellin L.E. Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal of Substance Abuse Treatment 2012, 43:433-439.
40. Tetrault J.M., Green M.L., Martino S., et al. Developing and implementing a multispecialty graduate medical education curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT). Substance Abuse 2012, 33:168-181.
41. von Wagner M., Huber M., Berg T., et al. Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology 2005, 129:522-527.
42. Zatzick D., Donovan D., Dunn C., Russo J., Wang J., Jurkovich G., Rivara F., Whiteside L., Ries R., Gentilello L. Substance use and posttraumatic stress disorder symptoms in trauma center patients receiving mandated alcohol screening and brief intervention. Journal of Substance Abuse Treatment 2012, 43:410-417.